Critical CareARDSmontelukast
TISA-818 in ARDS Due to Pulmonary Infection: Promising Safety and Early Efficacy Signals with the 2023 Global Definition
By MedXY|Oct 6, 2026
A phase 2 randomized trial shows that TISA-818, an anti-inflammatory montelukast-decapeptide conjugate, is safe and may improve respiratory outcomes in ARDS patients, especially non-intubated individuals, supporting larger trials.